Sana Biotechnology, Inc.
SANA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $103 | $71 | $96 | $128 |
| Short-Term Investments | $50 | $1 | $9 | $25 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $9 | $10 | $8 | $8 |
| Total Curr. Assets | $162 | $83 | $113 | $161 |
| Property Plant & Equip (Net) | $71 | $76 | $129 | $135 |
| Goodwill | $141 | $141 | $141 | $141 |
| Intangibles | $59 | $59 | $59 | $59 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $3 | $3 | $4 | $5 |
| Total NC Assets | $274 | $279 | $333 | $340 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $435 | $362 | $445 | $501 |
| Liabilities | – | – | – | – |
| Payables | $2 | $2 | $1 | $5 |
| Short-Term Debt | $15 | $14 | $13 | $13 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $19 | $17 | $19 | $28 |
| Total Curr. Liab. | $36 | $33 | $33 | $45 |
| LT Debt | $75 | $72 | $78 | $82 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $130 | $134 | $125 | $123 |
| Total NC Liab. | $205 | $206 | $203 | $205 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $90 | $85 | $91 | $94 |
| Total Liabilities | $240 | $239 | $236 | $251 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,790 | -$1,748 | -$1,654 | -$1,605 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $1,985 | $1,871 | $1,863 | $1,855 |
| Total Equity | $195 | $123 | $209 | $251 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $435 | $362 | $445 | $501 |
| Net Debt | -$14 | $14 | -$5 | -$33 |